UK's NICE endorses Remicade for ulcerative colitis
LONDON |
LONDON Dec 17 (Reuters) - Britain's healthcare cost-effectiveness watchdog NICE said on Wednesday it had recommended the use of Remicade as an option for treating acute exacerbations of ulcerative colitis. Remicade is sold in Europe by Schering-Plough Corp SGP.N.
The National Institute for Health and Clinical Excellence (NICE) said the drug could be considered for use on the state health service in patients for whom ciclosporin was not suitable.
Ulcerative colitis is a condition in which the lining of the large intestine becomes inflamed, causing bloody diarrhoea. (Reporting by Ben Hirschler; Editing by David Cowell)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters